BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16339689)

  • 1. Rescued mice with Hb E transgene-developed red cell changes similar to human beta-thalassemia/HbE disease.
    Wannasuphaphol B; Kalpravidh R; Pattanapanyasat K; Ioannau P; Kuypers FA; Fucharoen S; Winichagoon P
    Ann N Y Acad Sci; 2005; 1054():407-16. PubMed ID: 16339689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia.
    Jamsai D; Zaibak F; Vadolas J; Voullaire L; Fowler KJ; Gazeas S; Peters H; Fucharoen S; Williamson R; Ioannou PA
    Genomics; 2006 Sep; 88(3):309-15. PubMed ID: 16631345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations and pathology of thalassemic red cells: comparison between alpha- and beta-thalassemia.
    Bunyaratvej A; Fucharoen S; Butthep P; Sae-ung N; Kamchonwongpaisan S; Khuhapinant A
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():257-60. PubMed ID: 8629118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red cell parameters in alpha-thalassemia with and without beta-thalassemia trait or hemoglobin E trait.
    Jindadamrongwech S; Wisedpanichkij R; Bunyaratvej A; Hathirat P
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():97-9. PubMed ID: 9640607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical changes of red cells with thalassemia-like abnormal hemoglobin.
    Bunyaratvej A; Fucharoen S; Tatsumi N
    Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():86-90. PubMed ID: 1299000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of transgenic mice expressing human hemoglobin E.
    Chen Q; Bouhassira EE; Besse A; Suzuka SM; Fabry ME; Nagel RL; Hirsch RE
    Blood Cells Mol Dis; 2004; 33(3):303-7. PubMed ID: 15528149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A humanized mouse model for a common beta0-thalassemia mutation.
    Jamsai D; Zaibak F; Khongnium W; Vadolas J; Voullaire L; Fowler KJ; Gazeas S; Fucharoen S; Williamson R; Ioannou PA
    Genomics; 2005 Apr; 85(4):453-61. PubMed ID: 15780748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oxidative cross-linking of hemoglobin E with spectrin and loss of erythrocyte membrane asymmetry in hemoglobin Ebeta-thalassemia.
    Datta P; Basu S; Chakravarty SB; Chakravarty A; Banerjee D; Chandra S; Chakrabarti A
    Blood Cells Mol Dis; 2006; 37(2):77-81. PubMed ID: 16877015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.
    Chen Q; Fabry ME; Rybicki AC; Suzuka SM; Balazs TC; Etzion Z; de Jong K; Akoto EK; Canterino JE; Kaul DK; Kuypers FA; Lefer D; Bouhassira EE; Hirsch RE
    Blood Cells Mol Dis; 2012 Feb; 48(2):91-101. PubMed ID: 22260787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
    Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipid composition and organization in model beta-thalassemic erythrocytes.
    Kuypers FA; Schott MA; Scott MD
    Am J Hematol; 1996 Jan; 51(1):45-54. PubMed ID: 8571937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of phospholipid membrane asymmetry and sialylated glycoconjugates from erythrocyte surface in haemoglobin E beta-thalassaemia.
    Basu S; Banerjee D; Chandra S; Chakrabarti A
    Br J Haematol; 2008 Apr; 141(1):92-9. PubMed ID: 18324971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is hemoglobin instability important in the interaction between hemoglobin E and beta thalassemia?
    Rees DC; Clegg JB; Weatherall DJ
    Blood; 1998 Sep; 92(6):2141-6. PubMed ID: 9731073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia.
    de Franceschi L; Turrini F; Honczarenko M; Ayi K; Rivera A; Fleming MD; Law T; Mannu F; Kuypers FA; Bast A; van der Vijgh WJ; Brugnara C
    Haematologica; 2004 Nov; 89(11):1287-98. PubMed ID: 15531450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA-mediated reduction of alpha-globin results in phenotypic improvements in beta-thalassemic cells.
    Voon HP; Wardan H; Vadolas J
    Haematologica; 2008 Aug; 93(8):1238-42. PubMed ID: 18556409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin E-beta thalassemia: factors affecting phenotype.
    Panigrahi I; Agarwal S; Gupta T; Singhal P; Pradhan M
    Indian Pediatr; 2005 Apr; 42(4):357-62. PubMed ID: 15876597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia.
    de Jong K; Emerson RK; Butler J; Bastacky J; Mohandas N; Kuypers FA
    Blood; 2001 Sep; 98(5):1577-84. PubMed ID: 11520810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative treatment paradigm for thalassemia using iron chelators.
    Szuber N; Buss JL; Soe-Lin S; Felfly H; Trudel M; Ponka P
    Exp Hematol; 2008 Jul; 36(7):773-85. PubMed ID: 18456387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-globin gene cluster polymorphisms are strongly associated with severity of HbE/beta(0)-thalassemia.
    Ma Q; Abel K; Sripichai O; Whitacre J; Angkachatchai V; Makarasara W; Winichagoon P; Fucharoen S; Braun A; Farrer LA
    Clin Genet; 2007 Dec; 72(6):497-505. PubMed ID: 17894837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, hematological and molecular features in Thais with beta-Malay/beta-thalassemia and beta-Malay/HbE.
    Laosombat V; Wongchanchailert M; Sattayesevana B; Nopparatana C
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():106-9. PubMed ID: 9640610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.